T3 Pharmaceuticals

Biotechnology, Life Science, Therapeutics
Founded in 2015-01-01
Basel, Basel-Stadt, Switzerland
For Profit

About T3 Pharmaceuticals

The vision of T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments. Despite significant advances of classical therapies, there remains a high need for novel and innovative medicines to treat cancer. T3 Pharmaceuticals is dedicated to fill this gap by developing highly specific and efficient treatments using live bacteria.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: 274
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 37000000 CHF
  • Last Funding: None (Grant)
  • Funding Status: Late Stage Venture

Technology Stack

T3 Pharmaceuticals actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Life Science, Therapeutics

Headquarters: Basel, Basel-Stadt, Switzerland